AUSegdon

AUSegdon

Rosa hybrida shrub plant named ‘AUSegdon’

UNDER PATENT

Still under patent. Protection ends December 19, 2039.

No term adjustment or disclaimer is recorded against this patent, so this is the full statutory term — twenty years from the filing date.

Figure 1 of US plant patent PP32981, the photograph of AUSegdon printed in the patent.

Figure 1 from US Plant Patent PP32981, reproduced as printed. Photographs in a plant patent are taken by the applicant. Reproduction of the patent document is permitted; the image is shown whole and uncropped for that reason.

Abstract

An optical biomodule for detecting a disease specific biomarker(s), utilizing enhanced fluorescence emission (due to integration of a three-dimensional (3-D) protruded structure(s)) in a fluidic container/zero-mode waveguide, upon chemical binding of a disease specific biomarker(s) with its corresponding disease specific biomarker binder(s) is disclosed. The three-dimensional (3-D) protruded structure(s) can be coupled with a photonic crystal and/or a metamaterial and/or a metamaterial of Epsilon-Near-Zero (ENZ) of a suitable wavelength range. Furthermore, the enhanced fluorescence emission can be modulated by a synthetic Cas13 protein coupled with a CRISPR RNA (crRNA) and a quenched fluorescent reporter. Alternatively, a suitable synthetic substitute of a synthetic Cas13 protein coupled with a CRISPR RNA (crRNA) containing variable targeting sequence can also be utilized.

Show the legal claimThe single numbered claim as granted — the legal text that defines what this patent covers.

What is claimed is: 1. A new and distinct variety of rose plant of the shrub class, substantially as herein shown and described.

Read the full patent: US Plant Patent PP32981 in full — the complete specification, every figure, and the file history.

The record

Abstract